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Systematic search of bibliographic databases was conducted to describe the prevalence of dietary supplement use in cardiac
patients. Included for review were studies that investigated supplement use in people with cardiovascular risk factors or proven
cardiovascular disease. Databases searched were Medline, EMBASE, CINAHL, AMED, Meditext, H&S and IPA. Over ﬁve hundred
articles were retrieved and twenty studies met the criteria for this review. Dietary supplements were taken by a median 36%
(interquartile range: 26–42%) of cardiac patients; 36% (IQR 18–43%) reported taking a vitamin/mineral supplement and 12%
(IQR7–21%)usedherbalsupplements.Manyusersindicatedthatsupplementsweretakenspeciﬁcallyforhearthealthand16–64%
of users reported using supplements alongside prescription medications. However 39–95% of treating physicians were unaware of
patients’ supplement use. Dietary supplement use in patients with cardiovascular disease appears common, as does the concurrent
use of supplements with prescription medicines. This information is often not communicated to doctors and treating physicians
may need to be more proactive in asking about supplement use.
1.Introduction
A dietary supplement is deﬁned as “any product intended
for ingestion as a supplement to the diet” [1]. These
substances include amino acids, charcoal, choline salts,
essential oils, plant or herbal material, homeopathic prepa-
rations, nonvaccine microorganisms, minerals, nonhuman
animal material, lipids, substances from bees, and vitamins
or provitamins. In this paper, we use the term “dietary
supplement” to indicate any of these substances used as
complementary and alternative medicine (CAM) and taken
orally for the improvement of health or the prevention of
illness.
The use of dietary supplements is common; in the
general population, dietary supplements are the second most
commonly used type of CAM after prayer [2]. Dietary
supplements can interfere with the biotherapeutic action of
prescription medications, and this is of particular concern
in cardiac patients, many of whom are on long-term medica-
tionsandareatincreasedriskofacutelife-threateningevents.
Chronic conditions such as arthritis, cancer, depression, and
anxiety have been consistently associated with CAM use [3],
so it is probable that patients with chronic cardiovascular
diseasearealsolikelytouseCAM.Weconductedasystematic
review of the literature to ﬁnd the prevalence of dietary sup-
plement use by cardiac patients and to identify commonly
used supplements.
2. Method
2.1. Study Selection. A literature search was carried out on 2
December 2009. We searched the following databases from
their earliest availability up to and including November
2009:MedlinethroughOvidSPfrom1950,EMBASEthrough
embase.com from 1980, CINAHL through EBSCO Host
from 1982, Allied and Complementary Medicine (AMED)
throughOvidSPfrom1985,AustralianMedicalIndex(Medi-
text) through Informit from 1968, Health & Society (H&S)
through Informit from 1980, and International Pharmacy
Abstracts (IPA) through OvidSP from 1970.
MeSH keywords and qualiﬁers were used for databases
indexed using this method, that is, Medline and CINAHL.2 Evidence-Based Complementary and Alternative Medicine
n = 576
articles retrieved from search
n = 495
select empirical journal articles
n = 404
select studies focusing on dietary
supplements
n = 181
select studies focusing on samples
with cardiovascular disease
n = 31
select studies reporting rates of
supplement use
n = 81
duplicates excluded
n = 223 excluded
(e.g. other CAM, physical
therapies)
n = 11 excluded
(e.g. duplicated data, no data)
n = 91 excluded
(e.g. editorials, dissertations,
letters)
n = 20
articles included in paper
n = 150 excluded
(e.g. animal studies, physiology
studies, noncardiac samples)
Figure 1: Flowchart showing the selection of studies from search results.
We used the MeSH terms “cardiovascular diseases” with the
qualiﬁer “/therapy” to ﬁnd articles relevant to treatment of
cardiovasculardisease.Toﬁndarticlesondietarysupplement
use, we used the MeSH terms “medicine, traditional”,
“dietary supplements”, “vitamins”, “minerals”, each qualiﬁed
with “/utilization”. All MeSH terms were exploded to include
subheadings. The “cardiovascular disease” search results
were then intersected with each of the dietary supplement
searches. For databases not indexed using MeSH, searches
were performed using the same terms without the qualiﬁers.
In these databases, additional searches were conducted
using the terms “cardiovascular diseases”, “cardiology”, and
“cardiac” intersected with each of “complementary and
alternative medicine”, “dietary supplement”, and “herbal
medicine”. Search results were limited to articles in English
and those that dealt with humans where these options were
available.
The titles and abstracts of articles were read and reﬁned
to include only those studies that (i) reported the prevalence
of dietary supplement use, (ii) involved a sample of patients
either attending for cardiac care or those reporting a
cardiovascular condition, and (iii) indicated the types of
supplements used. If abstracts were not available or were
ambiguous with regard to these criteria, the full-text article
was obtained for inspection. Articles were excluded if (i)
study methods were not described, (ii) prevalence data on
dietarysupplementusewerenotreported(orthesecouldnot
be calculated from reported data), and if (iii) they were not
in English. Citations in the relevant papers were also used
to locate articles not found by the above methods. Figure 1
shows the selection of studies from the search results.
2.2. Data Extraction. Two data tables were designed for
systematic extraction of study information. Methodological
details were extracted and compared in Table 1, while study
content and results were extracted and summarised in
Table 2.ThemostcommonsupplementsarelistedinTable 3,
and for the sake of brevity, this only includes supplements
used by ≥1% of patients and which were reported in 2 or
more of the included studies.
2.3.StatisticalAnalyses. Prevalenceofoverallsupplementuse
was obtained from each study. For studies that did not report
the overall prevalence, the ﬁgure corresponding to the most
commonsupplementormostcommonsupplementcategory
was used. This method is expected to underestimate rather
than overestimate the total number of supplement users.
The median prevalence across studies and the corresponding
interquartile ranges (IQR) were calculated for (i) any supple-
ment use, (ii) the use of vitamin/mineral supplements, and
(iii) the use of herbal supplements. Where studies reported
useofindividualsupplements,datawasextractedandpooled
ﬁgures are presented in Table 3.Evidence-Based Complementary and Alternative Medicine 3
3. Results
3.1. Study Characteristics. Of the 576 studies found, 22
studies met the inclusion criteria. Twoof these were excluded
[4, 5] because they analysed subsets of the same data as
another study [6]. Therefore, 20 studies were included for
review [6–25].
All included studies were conducted between 1995 and
2008. Eleven were from the United States [6, 8, 9, 11–
14, 17, 18, 21, 25], three were from Canada [7, 19, 23]
and the others were from Hong Kong [22], India [20], Italy
[15], Nigeria [10], Turkey [24], and the United Kingdom
[16]. Three studies analysed data from population surveys
in the US [6, 11, 13], one contacted a registry of patients
with cardiovascular disease [23], and the others sampled
consecutive patients by convenience from their respective
hospital, outpatient, or specialist cardiology clinic [7–10, 12,
14–22, 24, 25]. Of the studies involving clinical samples, ﬁve
collected data by way of a patient-completed survey [7, 17–
19, 25], seven conducted face-to-face interviews [10, 12, 14–
16, 20, 24], two used a combination of telephone and face-
to-face interviews [8, 9], and two drew on information from
routine clinical examination [21, 22].
Thoroughness of methodological reporting varied
between studies (Table 1). Only three of the 16 clinical
studies commented on the representativeness of their sample
compared to the greater clinical population [7, 19, 23]. Six
did not report the survey response rate [9, 10, 14, 19, 21, 24].
For those that did, responding ranged from 26%–100%
(mean 74%). Only four of the clinical studies piloted their
survey instrument [7, 19, 24] and two trained multiple
interviewers to an equivalent standard [12, 23]. Four
performed a sample-size calculation to determine whether
there was suﬃcient statistical power to detect diﬀerences
between supplement users and nonusers [8, 14, 23, 25].
Many studies did not explicitly state what was meant by
“dietary supplement” or CAM and three studies did not
deﬁne the time period over which supplement use was
surveyed [9, 10, 23].
Six out of 20 studies surveyed the use of CAM as well
as dietary supplements [6, 8, 10, 12, 20, 23], which included
physical therapies such as chiropractic and yoga, and mind-
bodytherapiessuchasrelaxationandhypnosis.Anotherfour
included the use of nonprescription medications as well as
dietary supplements [7, 9, 11, 19]. Only results speciﬁc to
dietary supplements are reported in this paper.
3.2. Prevalence of Dietary Supplement Use. Any supplement
use was reported by a median 36% (IQR 26%–42%) of
patients across all 20 studies. Vitamins and minerals were
takenbyamedian36%(IQR18%–43%)ofpatientsacross17
studies.Herbalsubstancesweretakenbyamedian 12%(IQR
7%–21%) of patients across all 20 studies. Other supple-
ments (ﬁsh oil, glucosamine, homeopathy, etc.) were taken
byamedian7%ofpatients(IQR5%–10%)across14studies.
We also analysed results with respect to time periods
surveyed. Seven studies looked at ever or yearly use, ﬁnding
a median 25% of respondents used supplements (IQR 17%–
45%). Three or 6-month use was surveyed by four studies
with median 49% users (IQR 37%–61%). Median use within
thelastmonthinsixstudieswasfoundtobe39%(IQR37%–
40%). Only two studies investigated the duration of sup-
plement use, which averaged 39 months [24], with 88% of
herbaluserstakingthesupplementforamonthormore[13].
Supplement users tended to use more than one sup-
plement at a time: two studies reported an average of
2 supplements per user [14, 24], while another recorded
an average of 3 supplements per user [21]. Common
supplements used by cardiac patients are summarized in
Table 3 with the most common by far being multivitamins
and minerals.
3.3. Concomitant Use of Supplements and Prescription Med-
ications. Five studies reported data on the concomitant use
of prescription medication and dietary supplements [11, 13,
17, 20, 22, 23]. The study of Indian patients indicated 64%
wereusingCAMinconjunctionwithprescriptionantihyper-
tensives, although 86% had started conventional treatment
ﬁrst, while 9% had began CAM ﬁrst and 5% had started
both alternative and prescription treatments simultaneously
[20]. One population survey in the US indicated that 36%
of vitamin/mineral users and 16% of other supplement users
used prescription medication for cardiovascular health [11],
while another found that 63% of those with hypertension
and 64% of those with high cholesterol were found to
also take dietary supplements with their medications for
cardiovascular disease [13]. Thirteen percent of Canadian
patients with diagnosed coronary artery disease (CAD) had
used a dietary supplement in conjunction with warfarin,
amiodarone, sotalol, or digoxin [23], while 26% of Chinese
patients on warfarin had taken a herbal medicine in the
previous week [22]. Supplement users were as likely as
nonusers to be taking aspirin, betablockers, ACE inhibitors,
statins, and warfarin [17]. There was no diﬀerence between
herb users and nonusers in terms of indication for warfarin,
and the duration and dosage of warfarin therapy [22].
Three studies looked at the impact of supplement use
on compliance [10, 15, 16]. Of the two which surveyed
hypertensive patients [10, 16], one found no diﬀerence
between supplement users and nonusers on adherence to
antihypertensive medication [10], while the other found
that female supplement users had lower adherence to
prescription medications [16]. The third study that inves-
tigated outpatients with heart failure reported that 1 of 22
herbal supplement users reduced or interrupted heart failure
medications while taking herbal medicine [15].
3.4. Cardiovascular Health and Supplement Use. In patients
withheartfailure,upto82%ofsupplementusersweretaking
a supplement speciﬁcally for cardiovascular health [25]. In
patients with diagnosed cardiovascular disease, 18 out of 42
supplements (43%) were taken for a cardiac reason [14].
Supplement users were more likely than nonusers to
be under specialist cardiology care [9], although the use
of herbal supplements was not associated with previous
myocardial infarction or previous percutaneous coronary
intervention in a Turkish sample [24]. A US study [21]4 Evidence-Based Complementary and Alternative Medicine
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t
i
v
e
n
e
s
s
o
f
s
a
m
p
l
e
D
e
ﬁ
n
i
t
i
o
n
o
f
d
i
e
t
a
r
y
s
u
p
p
l
e
m
e
n
t
s
(
n
o
n
s
u
p
p
l
e
m
e
n
t
C
A
M
s
u
r
v
e
y
e
d
a
r
e
n
o
t
l
i
s
t
e
d
)
D
e
ﬁ
n
i
t
i
o
n
o
f
u
s
e
K
r
a
s
u
s
k
i
e
t
a
l
.
(
2
0
0
6
)
[
1
7
]
—
U
S
,
T
e
x
a
s
P
a
t
i
e
n
t
s
u
r
v
e
y
—
2
1
0
7
5
%
—
H
e
r
b
a
l
m
e
d
i
c
a
t
i
o
n
s
,
v
i
t
a
m
i
n
s
u
p
p
l
e
m
e
n
t
s
(
u
n
l
e
s
s
p
r
e
s
c
r
i
b
e
d
)
,
d
i
e
t
a
r
y
s
u
p
p
l
e
m
e
n
t
s
U
s
e
i
n
l
a
s
t
6
m
o
n
t
h
s
L
i
u
e
t
a
l
.
(
2
0
0
0
)
[
1
8
]
M
a
r
c
h
–
M
a
y
1
9
9
8
U
S
,
N
e
w
Y
o
r
k
P
a
t
i
e
n
t
s
u
r
v
e
y
—
2
6
3
7
0
%
—
C
h
e
l
a
t
i
o
n
,
h
e
r
b
s
,
h
o
m
e
o
p
a
t
h
y
,
n
a
t
u
r
o
p
a
t
h
y
,
n
u
t
r
i
t
i
o
n
a
l
t
h
e
r
a
p
y
,
v
i
t
a
m
i
n
s
E
v
e
r
u
s
e
d
P
h
a
r
a
n
d
e
t
a
l
.
(
2
0
0
3
)
[
1
9
]
D
e
c
e
m
b
e
r
1
9
9
8
–
F
e
b
r
u
a
r
y
1
9
9
9
C
a
n
a
d
a
,
c
r
o
s
s
-
c
o
u
n
t
r
y
P
a
t
i
e
n
t
s
u
r
v
e
y
S
u
r
v
e
y
u
s
e
d
i
n
A
c
k
m
a
n
e
t
a
l
.
(
1
9
9
9
)
[
7
]
3
0
6
—
R
e
s
p
o
n
d
e
n
t
s
d
i
s
t
r
i
b
u
t
e
d
a
c
r
o
s
s
c
o
u
n
t
r
y
s
i
m
i
l
a
r
l
y
t
o
p
o
p
u
l
a
t
i
o
n
V
i
t
a
m
i
n
s
o
r
m
i
n
e
r
a
l
p
r
o
d
u
c
t
s
,
n
u
t
r
i
t
i
o
n
a
l
s
u
p
p
l
e
m
e
n
t
s
,
h
e
a
l
t
h
f
o
o
d
o
r
h
e
r
b
a
l
p
r
o
d
u
c
t
s
(
h
o
m
e
r
e
m
e
d
i
e
s
,
o
r
i
e
n
t
a
l
r
e
m
e
d
i
e
s
)
U
s
e
d
d
a
i
l
y
o
r
a
t
l
e
a
s
t
o
n
c
e
w
e
e
k
l
y
i
n
l
a
s
t
6
m
o
n
t
h
s
S
h
a
ﬁ
q
e
t
a
l
.
(
2
0
0
3
)
[
2
0
]
M
a
y
2
0
0
1
–
O
c
t
o
b
e
r
2
0
0
1
I
n
d
i
a
,
C
h
a
n
d
i
g
a
r
h
F
a
c
e
-
t
o
-
f
a
c
e
i
n
t
e
r
v
i
e
w
—
5
2
1
1
0
0
%
—
H
e
r
b
a
l
m
e
d
i
c
i
n
e
,
h
o
m
e
o
p
a
t
h
y
C
u
r
r
e
n
t
a
n
d
p
a
s
t
u
s
e
S
t
y
s
e
t
a
l
.
(
2
0
0
4
)
[
2
1
]
—
U
S
,
N
e
w
Y
o
r
k
P
h
y
s
i
c
i
a
n
i
n
t
e
r
v
i
e
w
—
1
8
7
—
—
V
i
t
a
m
i
n
,
m
i
n
e
r
a
l
o
r
h
e
r
b
a
l
s
u
p
p
l
e
m
e
n
t
s
C
u
r
r
e
n
t
(
m
e
d
i
c
a
t
i
o
n
h
i
s
t
o
r
y
)
W
o
n
g
e
t
a
l
.
(
2
0
0
3
)
[
2
2
]
M
a
y
2
0
0
1
H
o
n
g
K
o
n
g
P
h
y
s
i
c
i
a
n
i
n
t
e
r
v
i
e
w
—
1
0
7
1
0
0
%
N
A
H
e
r
b
a
l
d
e
c
o
c
t
i
o
n
s
,
p
r
o
p
r
i
e
t
a
r
y
m
e
d
i
c
i
n
e
s
c
o
n
t
a
i
n
i
n
g
h
e
r
b
s
,
“
c
o
o
l
t
e
a
”
,
“
h
e
r
b
a
l
s
o
u
p
”
,
t
o
n
i
c
s
U
s
e
i
n
l
a
s
t
1
w
e
e
k
W
o
o
d
e
t
a
l
.
(
2
0
0
3
)
[
2
3
]
—
C
a
n
a
d
a
,
N
o
v
a
S
c
o
t
i
a
T
e
l
e
p
h
o
n
e
i
n
t
e
r
v
i
e
w
T
r
a
i
n
e
d
i
n
t
e
r
v
i
e
w
e
r
s
1
0
7
8
8
%
R
e
s
p
o
n
d
e
n
t
s
y
o
u
n
g
e
r
(
6
4
v
e
r
s
u
s
6
9
)
b
u
t
s
i
m
i
l
a
r
g
e
n
d
e
r
m
i
x
t
o
n
o
n
r
e
s
p
o
n
d
e
n
t
s
M
e
g
a
v
i
t
a
m
i
n
s
,
h
e
r
b
a
l
t
h
e
r
a
p
y
,
n
u
t
r
i
t
i
o
n
a
l
s
u
p
p
l
e
m
e
n
t
s
,
h
o
m
e
o
p
a
t
h
y
,
f
o
l
k
r
e
m
e
d
i
e
s
,
c
h
e
l
a
t
i
o
n
—
∗
Y
e
h
e
t
a
l
.
(
2
0
0
6
)
[
6
]
D
a
t
a
f
r
o
m
2
0
0
2
N
a
t
i
o
n
a
l
H
e
a
l
t
h
I
n
t
e
r
v
i
e
w
S
u
r
v
e
y
U
S
F
a
c
e
-
t
o
-
f
a
c
e
i
n
t
e
r
v
i
e
w
—
1
0
5
7
2
7
4
%
R
e
p
r
e
s
e
n
t
a
t
i
v
e
r
e
s
p
o
n
d
e
n
t
s
s
a
m
p
l
e
d
A
l
t
e
r
n
a
t
i
v
e
m
e
d
i
c
a
l
s
y
s
t
e
m
s
,
c
h
e
l
a
t
i
o
n
,
f
o
l
k
m
e
d
i
c
i
n
e
,
h
e
r
b
a
l
p
r
o
d
u
c
t
s
,
l
a
r
g
e
-
d
o
s
e
v
i
t
a
m
i
n
s
,
s
p
e
c
i
a
l
d
i
e
t
s
E
v
e
r
u
s
e
d
,
u
s
e
d
i
n
l
a
s
t
1
2
m
o
n
t
h
s
Y
i
l
m
a
z
e
t
a
l
.
(
2
0
0
7
)
[
2
4
]
—
T
u
r
k
e
y
F
a
c
e
-
t
o
-
f
a
c
e
i
n
t
e
r
v
i
e
w
S
u
r
v
e
y
p
i
l
o
t
e
d
3
1
0
—
—
H
e
r
b
a
l
s
E
v
e
r
u
s
e
d
,
u
s
e
d
a
i
l
y
,
d
u
r
a
t
i
o
n
o
f
u
s
e
Z
i
c
k
e
t
a
l
.
(
2
0
0
5
)
[
2
5
]
J
a
n
u
a
r
y
2
0
0
0
–
F
e
b
r
u
a
r
y
2
0
0
4
U
S
,
M
i
c
h
i
g
a
n
P
a
t
i
e
n
t
s
u
r
v
e
y
—
2
5
2
8
0
%
—
H
e
r
b
s
,
v
i
t
a
m
i
n
s
,
m
i
n
e
r
a
l
s
,
a
m
i
n
o
a
c
i
d
s
,
o
t
h
e
r
U
s
e
i
n
l
a
s
t
6
m
o
n
t
h
s
N
o
t
e
:
-
:
n
o
t
r
e
p
o
r
t
e
d
,
N
A
:
n
o
t
a
p
p
l
i
c
a
b
l
e
,
∗
S
t
u
d
y
a
n
a
l
y
s
e
d
d
a
t
a
f
r
o
m
a
p
o
p
u
l
a
t
i
o
n
s
u
r
v
e
y
.6 Evidence-Based Complementary and Alternative Medicine
T
a
b
l
e
2
:
C
o
m
p
a
r
i
s
o
n
o
f
r
e
s
u
l
t
s
i
n
s
t
u
d
i
e
s
o
f
d
i
e
t
a
r
y
s
u
p
p
l
e
m
e
n
t
u
s
e
i
n
c
a
r
d
i
a
c
p
a
t
i
e
n
t
s
.
S
t
u
d
y
S
e
t
t
i
n
g
C
l
i
n
i
c
a
l
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
s
a
m
p
l
e
M
e
a
n
a
g
e
o
f
s
a
m
p
l
e
(
S
D
;
r
a
n
g
e
)
%
f
e
m
a
l
e
E
t
h
n
i
c
c
o
m
p
o
s
i
t
i
o
n
P
r
e
v
a
l
e
n
c
e
o
f
s
u
p
p
l
e
m
e
n
t
u
s
e
A
s
s
o
c
i
a
t
i
o
n
s
b
e
t
w
e
e
n
c
a
r
d
i
o
v
a
s
c
u
l
a
r
h
e
a
l
t
h
,
m
e
d
i
c
a
t
i
o
n
a
n
d
s
u
p
p
l
e
m
e
n
t
u
s
e
R
e
a
s
o
n
s
f
o
r
u
s
e
P
h
y
s
i
c
i
a
n
a
w
a
r
e
n
e
s
s
A
c
k
m
a
n
e
t
a
l
.
(
1
9
9
9
)
[
7
]
H
o
s
p
i
t
a
l
c
l
i
n
i
c
D
i
a
g
n
o
s
e
d
c
o
n
g
e
s
t
i
v
e
h
e
a
r
t
f
a
i
l
u
r
e
6
9
(
−
)
3
7
%
—
V
i
t
a
m
i
n
s
/
m
i
n
e
r
a
l
s
5
9
%
N
u
t
r
i
t
i
o
n
a
l
s
u
p
p
l
e
m
e
n
t
s
1
7
%
H
e
a
l
t
h
f
o
o
d
/
h
e
r
b
a
l
p
r
o
d
u
c
t
s
3
8
%
U
s
e
u
n
r
e
l
a
t
e
d
t
o
C
H
F
s
e
v
e
r
i
t
y
—
—
A
i
a
n
d
B
o
l
l
i
n
g
(
2
0
0
2
)
[
8
]
C
a
r
d
i
a
c
c
l
i
n
i
c
A
d
m
i
t
t
e
d
f
o
r
n
o
n
-
e
m
e
r
g
e
n
c
y
/
n
o
n
-
t
r
a
n
s
p
l
a
n
t
s
u
r
g
e
r
y
6
2
.
4
(
3
6
–
8
4
)
4
4
%
—
M
e
g
a
v
i
t
a
m
i
n
s
1
3
%
H
e
r
b
s
a
n
d
f
o
l
k
r
e
m
e
d
i
e
s
1
2
%
H
o
m
e
o
p
a
t
h
y
4
%
—
—
—
A
l
b
e
r
t
e
t
a
l
.
(
2
0
0
9
)
[
9
]
H
o
s
p
i
t
a
l
s
a
n
d
c
a
r
d
i
o
l
o
g
y
p
r
a
c
t
i
c
e
s
D
i
a
g
n
o
s
e
d
h
e
a
r
t
f
a
i
l
u
r
e
6
9
.
6
(
±
1
3
.
1
;
3
1
–
9
8
)
3
7
%
8
1
%
C
a
u
c
a
s
i
a
n
M
u
l
t
i
v
i
t
a
m
i
n
s
/
m
i
n
e
r
a
l
s
3
6
%
H
e
r
b
a
l
t
h
e
r
a
p
y
1
2
%
6
0
%
u
s
e
r
s
t
a
k
e
w
i
t
h
p
r
e
s
c
r
i
p
t
i
o
n
m
e
d
i
c
a
t
i
o
n
U
s
e
r
s
m
o
r
e
l
i
k
e
l
y
t
h
a
n
n
o
n
u
s
e
r
s
t
o
b
e
u
n
d
e
r
c
a
r
d
i
o
l
o
g
i
s
t
c
a
r
e
,
h
a
v
e
h
i
g
h
c
h
o
l
e
s
t
e
r
o
l
,
d
i
a
b
e
t
e
s
b
u
t
n
o
t
s
i
g
n
i
ﬁ
c
a
n
t
l
y
d
i
ﬀ
e
r
e
n
t
e
j
e
c
t
i
o
n
f
r
a
c
t
i
o
n
P
r
o
m
o
t
e
o
r
m
a
i
n
t
a
i
n
g
o
o
d
h
e
a
l
t
h
4
5
%
–
4
7
%
O
v
e
r
a
l
l
w
e
l
l
b
e
i
n
g
3
0
%
–
4
2
%
E
n
e
r
g
y
/
d
e
c
r
e
a
s
e
f
a
t
i
g
u
e
1
3
%
–
2
5
%
—
A
m
i
r
a
a
n
d
O
k
u
b
a
d
e
j
o
(
2
0
0
7
)
[
1
0
]
H
y
p
e
r
t
e
n
s
i
o
n
c
l
i
n
i
c
D
i
a
g
n
o
s
e
d
h
y
p
e
r
t
e
n
s
i
o
n
5
5
.
1
(
±
1
2
.
4
)
6
0
%
—
D
i
e
t
a
r
y
s
u
p
p
l
e
m
e
n
t
s
a
n
d
h
e
r
b
s
9
7
%
U
s
e
r
s
h
a
d
h
i
g
h
e
r
B
M
I
(
2
9
v
e
r
s
u
s
2
7
)
b
u
t
n
o
d
i
ﬀ
e
r
e
n
t
o
n
b
l
o
o
d
p
r
e
s
s
u
r
e
r
e
a
d
i
n
g
s
o
r
d
u
r
a
t
i
o
n
o
f
h
y
p
e
r
t
e
n
s
i
o
n
.
U
s
e
r
s
n
o
d
i
ﬀ
e
r
e
n
t
o
n
m
e
d
i
c
a
t
i
o
n
c
o
m
p
l
i
a
n
c
e
a
n
d
b
l
o
o
d
p
r
e
s
s
u
r
e
c
o
n
t
r
o
l
—
—
A
r
t
z
e
t
a
l
.
(
2
0
0
6
)
[
1
1
]
C
o
m
m
u
n
i
t
y
T
a
k
i
n
g
n
o
n
p
r
e
s
c
r
i
p
t
i
o
n
m
e
d
i
c
a
t
i
o
n
f
o
r
c
a
r
d
i
a
c
r
e
a
s
o
n
—
6
9
%
—
V
i
t
a
m
i
n
/
m
i
n
e
r
a
l
s
u
p
p
l
e
m
e
n
t
3
8
%
N
o
n
v
i
t
a
m
i
n
/
m
i
n
e
r
a
l
s
u
p
p
l
e
m
e
n
t
2
1
%
3
6
%
v
i
t
a
m
i
n
/
m
i
n
e
r
a
l
s
u
p
p
l
e
m
e
n
t
u
s
e
r
s
a
n
d
1
6
%
o
t
h
e
r
s
u
p
p
l
e
m
e
n
t
u
s
e
r
s
a
l
s
o
t
a
k
e
p
r
e
s
c
r
i
p
t
i
o
n
c
a
r
d
i
a
c
m
e
d
i
c
a
t
i
o
n
—
—
B
a
r
r
a
c
o
e
t
a
l
.
(
2
0
0
5
)
[
1
2
]
H
o
s
p
i
t
a
l
c
a
r
d
i
o
l
o
g
y
u
n
i
t
S
u
s
p
e
c
t
e
d
a
c
u
t
e
c
o
r
o
n
a
r
y
s
y
n
d
r
o
m
e
6
6
.
2
(
±
1
3
.
4
)
3
9
%
7
9
%
C
a
u
c
a
s
i
a
n
,
1
3
%
A
f
r
i
c
a
n
-
A
m
e
r
i
c
a
n
H
e
r
b
a
l
s
5
%
A
n
t
i
-
o
x
i
d
a
n
t
s
4
%
M
i
n
e
r
a
l
s
3
%
—
—
—
B
u
e
t
t
n
e
r
e
t
a
l
.
(
2
0
0
7
)
[
1
3
]
#
C
o
m
m
u
n
i
t
y
S
e
l
f
-
r
e
p
o
r
t
e
d
C
A
D
/
s
t
r
o
k
e
o
r
h
y
p
e
r
t
e
n
s
i
o
n
/
h
i
g
h
c
h
o
l
e
s
t
e
r
o
l
C
A
D
/
s
t
r
o
k
e
6
6
(
−
)
h
y
p
e
r
t
e
n
s
i
o
n
/
h
i
g
h
c
h
o
l
e
s
t
e
r
o
l
5
8
(
−
)
4
6
%
/
5
7
%
8
0
%
/
7
8
%
W
h
i
t
e
,
1
0
%
/
1
0
%
B
l
a
c
k
,
3
%
/
4
%
M
e
x
i
c
a
n
-
A
m
e
r
i
c
a
n
M
u
l
t
i
v
i
t
a
m
i
n
3
6
%
–
4
0
%
M
i
n
e
r
a
l
s
9
%
–
1
1
%
H
e
r
b
s
7
%
–
1
0
%
O
t
h
e
r
s
u
p
p
l
e
m
e
n
t
s
6
%
-
7
%
O
f
c
a
r
d
i
a
c
m
e
d
i
c
a
t
i
o
n
u
s
e
r
s
:
M
u
l
t
i
v
i
t
a
m
i
n
3
6
%
–
4
0
%
M
i
n
e
r
a
l
s
2
5
%
–
3
0
%
H
e
r
b
s
6
%
–
9
%
O
t
h
e
r
s
u
p
p
l
e
m
e
n
t
s
6
%
-
7
%
O
f
t
h
o
s
e
t
a
k
i
n
g
m
e
d
i
c
a
t
i
o
n
f
o
r
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
,
6
3
%
o
f
t
h
o
s
e
w
i
t
h
p
r
e
v
i
o
u
s
C
A
D
/
s
t
r
o
k
e
a
n
d
6
4
%
o
f
t
h
o
s
e
w
i
t
h
h
y
p
e
r
t
e
n
s
i
o
n
/
h
i
g
h
c
h
o
l
e
s
t
e
r
o
l
a
l
s
o
u
s
e
d
a
s
u
p
p
l
e
m
e
n
t
C
A
D
/
s
t
r
o
k
e
g
r
o
u
p
m
o
r
e
l
i
k
e
l
y
t
o
u
s
e
v
i
t
a
m
i
n
E
,
B
v
i
t
a
m
i
n
s
a
n
d
l
e
s
s
l
i
k
e
l
y
t
o
u
s
e
ﬁ
s
h
o
i
l
;
h
y
p
e
r
t
e
n
s
i
o
n
/
h
i
g
h
c
h
o
l
e
s
t
e
r
o
l
g
r
o
u
p
m
o
r
e
l
i
k
e
l
y
t
o
u
s
e
g
a
r
l
i
c
a
n
d
g
i
n
s
e
n
g
—
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T
a
b
l
e
2
:
C
o
n
t
i
n
u
e
d
.
S
t
u
d
y
S
e
t
t
i
n
g
C
l
i
n
i
c
a
l
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
s
a
m
p
l
e
M
e
a
n
a
g
e
o
f
s
a
m
p
l
e
(
S
D
;
r
a
n
g
e
)
%
f
e
m
a
l
e
E
t
h
n
i
c
c
o
m
p
o
s
i
t
i
o
n
P
r
e
v
a
l
e
n
c
e
o
f
s
u
p
p
l
e
m
e
n
t
u
s
e
A
s
s
o
c
i
a
t
i
o
n
s
b
e
t
w
e
e
n
c
a
r
d
i
o
v
a
s
c
u
l
a
r
h
e
a
l
t
h
,
m
e
d
i
c
a
t
i
o
n
a
n
d
s
u
p
p
l
e
m
e
n
t
u
s
e
R
e
a
s
o
n
s
f
o
r
u
s
e
P
h
y
s
i
c
i
a
n
a
w
a
r
e
n
e
s
s
C
h
a
g
a
n
e
t
a
l
.
(
2
0
0
5
)
[
1
4
]
H
o
s
p
i
t
a
l
c
l
i
n
i
c
D
i
a
g
n
o
s
e
d
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
u
s
e
r
s
6
1
.
4
(
±
1
6
.
7
)
n
o
n
u
s
e
r
s
5
8
.
7
(
±
1
6
.
3
)
4
0
%
5
0
%
W
h
i
t
e
,
2
3
%
A
f
r
i
c
a
n
-
A
m
e
r
i
c
a
n
,
1
5
%
H
i
s
p
a
n
i
c
,
1
2
%
o
t
h
e
r
“
B
i
o
l
o
g
i
c
a
l
-
b
a
s
e
d
t
h
e
r
a
p
y
”
:
e
v
e
r
u
s
e
d
4
8
%
,
u
s
e
d
i
n
l
a
s
t
1
2
m
o
n
t
h
s
4
2
%
N
o
d
i
ﬀ
e
r
e
n
c
e
i
n
u
s
e
r
s
a
n
d
n
o
n
u
s
e
r
s
i
n
n
u
m
b
e
r
o
f
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
s
.
A
v
e
r
a
g
e
o
f
2
s
u
p
p
l
e
m
e
n
t
s
a
n
d
7
p
r
e
s
c
r
i
p
t
i
o
n
m
e
d
i
c
a
t
i
o
n
s
u
s
e
d
p
e
r
p
a
t
i
e
n
t
.
4
2
p
o
t
e
n
t
i
a
l
i
n
t
e
r
a
c
t
i
o
n
s
i
d
e
n
t
i
ﬁ
e
d
,
m
o
s
t
c
o
m
m
o
n
l
y
a
s
p
i
r
i
n
a
n
d
v
i
t
a
m
i
n
E
i
n
1
6
p
a
t
i
e
n
t
s
1
8
o
f
4
2
s
u
p
p
l
e
m
e
n
t
s
t
a
k
e
n
f
o
r
a
c
a
r
d
i
a
c
r
e
a
s
o
n
7
5
%
u
s
e
r
s
p
e
r
c
e
i
v
e
s
a
f
e
,
7
0
%
e
ﬀ
e
c
t
i
v
e
,
4
5
%
b
e
l
i
e
v
e
c
a
u
s
e
f
e
w
e
r
s
i
d
e
e
ﬀ
e
c
t
s
t
h
a
n
p
r
e
s
c
r
i
p
t
i
o
n
m
e
d
i
c
a
t
i
o
n
4
0
%
p
h
y
s
i
c
i
a
n
s
u
n
a
w
a
r
e
6
7
%
o
f
u
s
e
r
s
w
e
r
e
n
o
t
a
s
k
e
d
b
y
p
h
y
s
i
c
i
a
n
s
a
b
o
u
t
u
s
e
D
a
l
C
o
r
s
o
e
t
a
l
.
(
2
0
0
7
)
[
1
5
]
O
u
t
p
a
t
i
e
n
t
h
e
a
r
t
f
a
i
l
u
r
e
c
l
i
n
i
c
C
l
i
n
i
c
p
a
t
i
e
n
t
s
6
5
.
7
(
±
1
0
)
1
1
%
—
V
i
t
a
m
i
n
s
/
m
i
n
e
r
a
l
s
2
1
%
H
e
r
b
a
l
m
e
d
i
c
i
n
e
9
%
O
n
l
y
1
p
a
t
i
e
n
t
f
r
o
m
1
5
3
r
e
d
u
c
e
d
a
n
d
i
n
t
e
r
r
u
p
t
e
d
h
e
a
r
t
f
a
i
l
u
r
e
t
a
b
l
e
t
s
—
3
9
%
d
i
d
n
o
t
r
e
p
o
r
t
h
e
r
b
a
l
u
s
e
t
o
d
o
c
t
o
r
s
4
4
%
d
i
d
n
o
t
r
e
p
o
r
t
v
i
t
a
m
i
n
/
m
i
n
e
r
a
l
u
s
e
G
o
h
a
r
e
t
a
l
.
(
2
0
0
8
)
[
1
6
]
O
u
t
p
a
t
i
e
n
t
h
y
p
e
r
t
e
n
s
i
o
n
c
l
i
n
i
c
C
l
i
n
i
c
p
a
t
i
e
n
t
s
5
7
.
3
(
±
1
6
)
4
6
%
6
4
%
W
h
i
t
e
E
u
r
o
p
e
a
n
,
2
5
%
S
o
u
t
h
A
s
i
a
n
,
1
1
%
A
f
r
o
-
C
a
r
i
b
b
e
a
n
A
n
y
b
i
o
l
o
g
i
c
a
l
-
b
a
s
e
d
t
h
e
r
a
p
y
2
9
%
V
i
t
a
m
i
n
s
u
p
p
l
e
m
e
n
t
s
2
0
%
D
i
e
t
a
r
y
s
u
p
p
l
e
m
e
n
t
s
1
1
%
H
e
r
b
a
l
m
e
d
i
c
i
n
e
7
%
—
—
—
K
r
a
s
u
s
k
i
e
t
a
l
.
(
2
0
0
6
)
[
1
7
]
O
u
t
p
a
t
i
e
n
t
c
a
r
d
i
o
l
o
g
y
c
l
i
n
i
c
R
e
t
u
r
n
i
n
g
c
l
i
n
i
c
p
a
t
i
e
n
t
s
6
6
.
2
(
±
1
1
.
6
)
3
2
%
—
M
u
l
t
i
v
i
t
a
m
i
n
s
6
8
%
N
o
d
i
ﬀ
e
r
e
n
c
e
b
e
t
w
e
e
n
u
s
e
r
s
a
n
d
n
o
n
u
s
e
r
s
o
n
u
s
e
o
f
a
s
p
i
r
i
n
,
b
e
t
a
b
l
o
c
k
e
r
s
,
A
C
E
-
i
n
h
i
b
i
t
o
r
s
,
s
t
a
t
i
n
s
o
r
C
o
u
m
a
d
i
n
G
r
e
a
t
e
r
b
e
n
e
ﬁ
t
t
h
a
n
p
r
e
s
c
r
i
p
t
i
o
n
1
5
%
,
s
a
f
e
r
t
h
a
n
p
r
e
s
c
r
i
p
t
i
o
n
4
5
%
,
n
o
i
n
t
e
r
a
c
t
i
o
n
s
4
7
%
5
0
%
d
i
d
n
o
t
i
n
f
o
r
m
c
a
r
d
i
o
l
o
g
i
s
t
s
L
i
u
e
t
a
l
.
(
2
0
0
0
)
[
1
8
]
C
a
r
d
i
o
t
h
o
r
a
c
i
c
s
u
r
g
e
r
y
c
l
i
n
i
c
P
a
t
i
e
n
t
s
a
t
t
e
n
d
i
n
g
c
l
i
n
i
c
4
1
%
a
g
e
d
4
0
–
6
5
,
5
1
%
a
g
e
d
o
v
e
r
6
5
2
8
%
7
6
%
W
h
i
t
e
,
7
%
A
f
r
i
c
a
n
A
m
e
r
i
c
a
n
,
6
%
H
i
s
p
a
n
i
c
,
6
%
N
a
t
i
v
e
A
m
e
r
i
c
a
n
V
i
t
a
m
i
n
s
5
4
%
H
e
r
b
s
1
0
%
H
o
m
e
o
p
a
t
h
y
3
%
—
—
—
P
h
a
r
a
n
d
e
t
a
l
.
(
2
0
0
3
)
[
1
9
]
H
o
s
p
i
t
a
l
w
a
r
d
,
o
u
t
p
a
t
i
e
n
t
c
l
i
n
i
c
a
n
d
e
m
e
r
g
e
n
c
y
r
o
o
m
D
i
a
g
n
o
s
e
d
w
i
t
h
C
H
F
o
r
C
A
D
f
o
r
a
t
l
e
a
s
t
6
m
o
n
t
h
s
6
6
(
4
0
%
o
v
e
r
7
0
)
4
1
%
—
M
u
l
t
i
v
i
t
a
m
i
n
/
m
i
n
e
r
a
l
2
3
%
S
i
n
g
l
e
-
e
n
t
i
t
y
v
i
t
a
m
i
n
/
m
i
n
e
r
a
l
3
8
%
H
e
r
b
a
l
p
r
o
d
u
c
t
1
7
%
—
—
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T
a
b
l
e
2
:
C
o
n
t
i
n
u
e
d
.
S
t
u
d
y
S
e
t
t
i
n
g
C
l
i
n
i
c
a
l
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
s
a
m
p
l
e
M
e
a
n
a
g
e
o
f
s
a
m
p
l
e
(
S
D
;
r
a
n
g
e
)
%
f
e
m
a
l
e
E
t
h
n
i
c
c
o
m
p
o
s
i
t
i
o
n
P
r
e
v
a
l
e
n
c
e
o
f
s
u
p
p
l
e
m
e
n
t
u
s
e
A
s
s
o
c
i
a
t
i
o
n
s
b
e
t
w
e
e
n
c
a
r
d
i
o
v
a
s
c
u
l
a
r
h
e
a
l
t
h
,
m
e
d
i
c
a
t
i
o
n
a
n
d
s
u
p
p
l
e
m
e
n
t
u
s
e
R
e
a
s
o
n
s
f
o
r
u
s
e
P
h
y
s
i
c
i
a
n
a
w
a
r
e
n
e
s
s
S
h
a
ﬁ
q
e
t
a
l
.
(
2
0
0
3
)
[
2
0
]
H
o
s
p
i
t
a
l
h
y
p
e
r
t
e
n
s
i
o
n
c
l
i
n
i
c
P
a
t
i
e
n
t
s
a
t
t
e
n
d
i
n
g
c
l
i
n
i
c
7
1
%
a
g
e
d
o
v
e
r
5
0
,
2
6
%
a
g
e
d
3
6
–
5
0
,
3
%
a
g
e
d
1
8
–
2
5
2
6
%
—
A
y
u
r
v
e
d
a
5
7
%
H
e
r
b
a
l
m
e
d
i
c
i
n
e
1
4
%
H
o
m
e
o
p
a
t
h
y
8
%
—
A
d
v
e
r
s
e
r
e
a
c
t
i
o
n
s
o
f
c
o
n
v
e
n
t
i
o
n
a
l
t
h
e
r
a
p
y
5
9
%
R
e
c
o
m
m
e
n
d
e
d
b
y
f
a
m
i
l
y
/
f
r
i
e
n
d
s
6
2
%
5
%
i
n
f
o
r
m
e
d
d
o
c
t
o
r
s
a
b
o
u
t
C
A
M
S
t
y
s
e
t
a
l
.
(
2
0
0
4
)
[
2
1
]
P
r
e
v
e
n
t
i
v
e
c
a
r
d
i
o
l
o
g
y
c
l
i
n
i
c
P
a
t
i
e
n
t
s
a
t
t
e
n
d
i
n
g
c
l
i
n
i
c
6
1
(
±
1
4
)
2
8
%
—
V
i
t
a
m
i
n
s
5
3
%
H
e
r
b
s
2
1
%
1
o
r
m
o
r
e
s
u
p
p
l
e
m
e
n
t
s
5
7
%
A
v
e
r
a
g
e
o
f
3
s
u
p
p
l
e
m
e
n
t
s
p
e
r
u
s
e
r
U
s
e
r
s
m
o
r
e
l
i
k
e
l
y
t
o
h
a
v
e
e
s
t
a
b
l
i
s
h
e
d
C
A
D
,
f
a
m
i
l
y
h
i
s
t
o
r
y
o
f
p
r
e
m
a
t
u
r
e
C
A
D
,
h
i
g
h
e
r
t
o
t
a
l
c
h
o
l
e
s
t
e
r
o
l
,
h
i
g
h
e
r
H
D
L
a
n
d
u
s
e
s
t
a
t
i
n
s
U
s
e
r
s
a
n
d
n
o
n
u
s
e
r
s
h
a
v
e
s
i
m
i
l
a
r
b
l
o
o
d
p
r
e
s
s
u
r
e
a
n
d
H
b
A
1
c
l
e
v
e
l
s
—
—
W
o
n
g
e
t
a
l
.
(
2
0
0
3
)
[
2
2
]
W
a
r
f
a
r
i
n
c
l
i
n
i
c
P
a
t
i
e
n
t
s
a
t
t
e
n
d
i
n
g
c
l
i
n
i
c
U
s
e
r
s
5
6
.
5
(
±
1
2
.
4
)
N
o
n
u
s
e
r
s
5
6
.
4
(
±
1
1
.
7
)
5
9
%
—
H
e
r
b
a
l
m
e
d
i
c
i
n
e
2
6
%
I
N
R
f
o
r
u
s
e
r
s
l
o
w
e
r
t
h
a
n
f
o
r
n
o
n
u
s
e
r
s
N
o
d
i
ﬀ
e
r
e
n
c
e
b
e
t
w
e
e
n
h
e
r
b
a
l
u
s
e
r
s
a
n
d
n
o
n
u
s
e
r
s
i
n
i
n
d
i
c
a
t
i
o
n
f
o
r
W
a
r
f
a
r
i
n
,
d
u
r
a
t
i
o
n
o
f
W
a
r
f
a
r
i
n
t
h
e
r
a
p
y
o
r
W
a
r
f
a
r
i
n
d
o
s
a
g
e
—
—
W
o
o
d
e
t
a
l
.
(
2
0
0
3
)
[
2
3
]
R
e
g
i
s
t
r
y
o
f
p
a
t
i
e
n
t
s
w
i
t
h
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
P
r
e
v
i
o
u
s
l
y
h
o
s
p
i
t
a
l
i
s
e
d
w
i
t
h
i
s
c
h
a
e
m
i
c
h
e
a
r
t
d
i
s
e
a
s
e
,
C
H
F
o
r
A
F
6
4
.
3
(
±
1
1
.
9
)
3
5
%
—
M
e
g
a
d
o
s
e
v
i
t
a
m
i
n
s
3
5
%
H
e
r
b
a
l
s
u
p
p
l
e
m
e
n
t
s
3
2
%
N
o
n
-
h
e
r
b
a
l
s
u
p
p
l
e
m
e
n
t
s
2
2
%
O
f
2
4
p
a
t
i
e
n
t
s
t
a
k
i
n
g
w
a
r
f
a
r
i
n
,
a
m
i
o
d
a
r
o
n
e
,
s
o
t
a
l
o
l
,
o
r
d
i
g
o
x
i
n
,
5
0
%
a
l
s
o
u
s
e
d
v
i
t
a
m
i
n
,
3
6
%
h
e
r
b
a
l
,
3
6
%
n
o
n
-
h
e
r
b
a
l
s
u
p
p
l
e
m
e
n
t
P
o
t
e
n
t
i
a
l
i
m
p
r
o
v
e
m
e
n
t
i
n
c
o
n
d
i
t
i
o
n
5
7
%
,
p
r
o
v
e
n
b
e
n
e
ﬁ
t
2
8
%
,
d
i
s
s
a
t
i
s
ﬁ
e
d
w
i
t
h
c
o
n
v
e
n
t
i
o
n
a
l
t
r
e
a
t
m
e
n
t
1
7
%
—
Y
e
h
e
t
a
l
.
(
2
0
0
6
)
[
6
]
C
o
m
m
u
n
i
t
y
S
e
l
f
-
r
e
p
o
r
t
e
d
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
3
5
%
a
g
e
d
6
5
a
n
d
o
v
e
r
;
3
1
%
a
g
e
d
5
0
–
6
4
5
3
%
8
2
%
W
h
i
t
e
,
1
3
%
B
l
a
c
k
,
5
%
o
t
h
e
r
H
i
g
h
-
d
o
s
e
v
i
t
a
m
i
n
s
3
%
H
e
r
b
a
l
t
h
e
r
a
p
i
e
s
1
8
%
S
i
m
i
l
a
r
r
a
t
e
s
o
f
v
i
t
a
m
i
n
a
n
d
h
e
r
b
a
l
u
s
e
i
n
t
h
o
s
e
w
i
t
h
a
n
d
w
i
t
h
o
u
t
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
8
0
%
h
e
r
b
a
l
u
s
e
r
s
p
e
r
c
e
i
v
e
d
h
e
r
b
s
t
o
b
e
h
e
l
p
f
u
l
5
6
%
d
i
d
n
o
t
d
i
s
c
l
o
s
e
h
e
r
b
a
l
u
s
e
Y
i
l
m
a
z
e
t
a
l
.
(
2
0
0
7
)
[
2
4
]
O
u
t
p
a
t
i
e
n
t
c
a
r
d
i
o
l
o
g
y
c
l
i
n
i
c
A
d
m
i
t
t
e
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Table 3: Common supplements used by cardiac patients, pooled results from included studies.
Supplement Number of studies Pooled n Pooled sample Pooled prevalence (%)
aloe vera 2 15 423 3.6
Bilberry 2 4 439 1.0
Calcium 6 1,017 4,629 22.0
cayenne pepper/capsicum 2 26 486 5.3
chromium/chromium picolinate 3 11 679 1.6
coenzyme Q10 7 58 2,335 2.5
Dandelion 2 4 359 1.0
Echinacea 5 705 11,503 6.1
ﬁsh oil/omega-3 7 279 14,014 2.0
ﬂax seed/ﬂax seed oil 5 48 1,235 3.9
folic acid 7 160 5,108 3.1
Garlic 12 902 16,417 5.5
Ginger 6 302 11,909 2.5
ginkgo biloba 6 572 15,131 3.8
Ginseng 8 502 14,471 3.5
glucosamine/chondroitin 8 499 11,855 4.2
green tea 4 61 931 6.6
Hawthorn 4 13 913 1.4
Iron 4 26 673 3.9
Kelp 2 7 486 1.4
Lecithin 3 8 492 1.6
multivitamins and minerals 9 1,883 5,525 34.1
Magnesium 6 50 1,352 3.7
mint/lemon balm 2 44 417 10.7
Nettle 3 68 864 7.9
Parsley 4 214 10,824 2.0
Peppermint 2 214 10,824 2.0
Potassium 3 87 4,034 2.2
Sage 2 29 417 7.0
saw palmetto 4 32 1,023 3.1
Selenium 2 8 385 2.0
St John’s wort 3 220 11,053 2.0
Valerian 3 24 882 2.7
vitamin A/beta-carotene 6 107 4,671 2.3
vitamin B/B12/B complex 8 470 5,261 8.9
vitamin C 9 768 5,408 14.2
vitamin D 4 42 1,047 4.0
vitamin E 8 1,056 5,318 19.9
Zinc 5 37 1,123 3.3
Note: Only supplements with reported ≥1% use in 2 or more studies were included. Some ﬁgures were calculated from reported percentages.
did ﬁnd higher supplement use in those with signiﬁcant
CAD (deﬁned as prior myocardial infarction or previous
percutaneous coronary intervention), and the studies of Ai
and Bolling [8, 26] showed that use of herbs and folk
remedies were signiﬁcantly associated with arrhythmia and
left main disease. Six studies speciﬁcally investigated patients
with congestive heart failure (CHF) [7, 14, 15, 19, 23, 25]. In
thispopulation,supplementusewasreportedtobe40%[23]
and82%[25]althoughuseappearedunrelatedtotheseverity
of CHF [7] or left ventricular ejection fraction [9, 21].
Four studies reported data on measurable outcomes. In
Chinesepatientstakingwarfarin,INRwassigniﬁcantlylower
in herbal users than nonusers [22]. In two separate studies
[10, 21] of clinic outpatients, blood pressure control did
not diﬀer between supplement users and nonusers although
herbalusewasassociatedwithlowerbloodpressureinelderly
patients with heart failure [9]. In one clinic population, low-
density lipoprotein (LDL) levels also did not diﬀer between
supplement users and nonusers but high-density lipoprotein
(HDL) was higher among the supplement users [21].10 Evidence-Based Complementary and Alternative Medicine
3.5.PatientPerceptionsofDietarySupplements. Sevenstudies
investigated patient perceptions of dietary supplements [6,
9, 14, 17, 20, 23, 24]. The most common reasons for
supplement use were: to promote or maintain health (up
to 47%), for overall wellbeing (up to 42%), and for energy
(up to 25%) [9]. Dissatisfaction with conventional treatment
was cited by 17% of patients in one study as a reason for
supplement use [23] while in another, 59% cited fear of
adverse drug reactions as the reason for using CAM [20].
Three times more supplement users than nonusers thought
supplements were safe (75% versus 26%) [14], with 45%
of users believing supplements were safer than prescription
medications [15], 30% indicating that supplements were
less likely to interact with other medicines [17], and 45%–
47% thinking that supplements would result in fewer side
eﬀects compared to prescription medications [14, 17]. Two
studies found that 47% [17] and 81% [24]o fu s e r s ,
respectively, were unaware herbal medicines could impact
negativelyonprescriptionmedications.Dietarysupplements
were viewed as eﬀective by 70%–80% of supplement users
[6, 14].
Only one study uncovered negative views of CAM [20],
ﬁndingthat56%ofpatientsweredissatisﬁedwithCAM.Two
thirds of these patients thought CAM was too expensive and
the rest believed that CAM caused adverse eﬀects. The same
study reported exacerbated hypertension made up 74% of
the adverse eﬀects attributed by patients to CAM use [20]
and all patients who reported adverse eﬀects subsequently
discontinued CAM use.
3.6. Physician Awareness of Patients’ Supplement Use. Six
studies asked whether patients informed doctors about
supplement use and found physicians were not notiﬁed
44% (IQR 40%–53%) of the time [6, 14, 15, 17, 20, 24].
One study reported that 67% of supplement users did not
disclose supplement use because their doctors did not ask
[14], but other studies did not investigate the reasons behind
nondisclosure.
4. Discussion
This is the ﬁrst systematic review of dietary supplement use
in cardiac patients and the ﬁndings have strong implications
for clinical practice. The results indicate that supplement
use is common in cardiac patients (26%–42%) and that the
concomitant use of dietary supplements and prescription
medicine also appears to be frequent (16%–64%). Sicker
patientsmaybemorelikelytoseekoutalternativetreatments
[8, 13, 21], and drug interaction could play a causal role
in the lower INR observed among supplement users on
warfarin [22] or in the lower blood pressure among cardiac
failure patients [9].
The potential for negative interaction in supplement
users is high. Substances such as ﬁsh oil, hawthorn,
garlic, ginseng, ginkgo, glucosamine, and parsley have
antiplatelet properties [27, 28] and may interact with pre-
scription antiplatelets or anticoagulants. Supplements such
as capsicum and ginseng have been shown to aﬀect blood
pressure [29]. Supplemental potassium was taken by 1 in
5 respondents in one study [7]; this may result in adverse
outcomes when used in combination with commonly pre-
scribed cardiovascular medications such as angiotensin con-
verting enzyme inhibitors, aldosterone receptor antagonists,
or angiotensin receptor blockers. Other researchers have
thoroughly reviewed the eﬀects of herbal medicines and
dietary supplements for cardiovascular health [30]a sw e l l
as their potential for drug interaction [31]a n dw er e f e r
clinicians to these resources for more details.
Itis worthnoting thatpatients arelikely to be using more
than one supplement at a time [21], for periods of months
to years [13, 24]. This raises concerns of possible ongoing
adverse interaction between supplements and prescription
medications, as well as the potential for negative eﬀects on
compliancewithconventionaltherapy.Manypatientsbelieve
supplements are safe, eﬀective, and produce few side eﬀects.
Many are also unaware that supplements can negatively
impact prescription medications [14, 15, 24]. Moreover, a
large proportion of physicians (39%–95%) are unaware of
supplement use by their patients. Although patients may
be reluctant to disclose supplement use, the main reason
for nondisclosure appears to be physicians not asking about
supplement use [14]. This suggests physicians can produce
signiﬁcant change in this aspect by being more proactive and
asking about supplement use.
There are inconsistent results with regard to the asso-
ciation between supplement use and compliance. There is
also limited evidence on whether supplement use aﬀects
clinical outcomes such as blood pressure and cholesterol
control. The available evidence suggests that supplement
use is associated with diﬀerences in health status of cardiac
patients, although it is unknown whether supplement use
causes these diﬀerences or whether diﬀerences in health
cause patients to self-manage through supplementation.
The aggregated results presented here should be treated
with caution. Our results show wide variability in the
prevalence of dietary supplement use, which is consistent
with other reviews of the CAM literature [32, 33]. Some
of these variations may be due to the country and year in
which the study was conducted. For the North American
studies, the range of ﬁgures is smaller than for all studies
but still large. For vitamin/mineral use it is 38% (IQR 26–
49), for herbals 10% (IQR 7–18), and for other supplements
7% (IQR 5%–13%). In terms of variations over time, rates
of supplement use seem to be decreasing over time, the
overall rates being negatively correlated to the publication
year in the North American studies (r =− 0.30). However,
there are also severe methodological limitations in the
quality and comparability of the reviewed studies. For
instance, even though many of the included studies involved
clinical samples, few provided objective data on the health
status of the patients. Clinical diagnoses of cardiovascular
disease were reported in only seven studies [7, 9, 10,
14, 19, 23, 25], and only six compared supplement users
and nonusers on clinical outcomes [7, 9, 10, 17, 21, 22].
Study comparison was also diﬃcult due to heterogeneity
in the deﬁnitions of dietary supplements and supplement
use. For instance, some studies did not include commonEvidence-Based Complementary and Alternative Medicine 11
vitamins and supplements in their surveys, which would
radically reduce the rates of supplement use. Some studies
provided a checklist of supplements with no room for
respondents to list other substances they may have used.
Across studies, patients were asked whether they had used
dietary supplements in the past year [6, 8, 12, 14, 16], in
the past month [13], in the past 3 and 6 months [7, 17,
19, 25], as well as whether ever used in lifetime [15, 18].
Two studies deﬁned regular use as “at least once weekly”
[7, 19] and only one asked for the duration of use [24].
An obvious result of using dissimilar deﬁnitions are the
disparate prevalence rates even in the largest population
studies, all conducted in North America [6, 11, 13], which
found supplement use to be 36%, 61%, and 22%, respec-
tively.
Future studies should focus on developing three main
areas. The ﬁrst is to standardise and make explicit the
deﬁnitions of dietary supplements and supplement use,
whichwillfacilitatecross-studycomparison[33].Thesecond
is to examine the impact of supplement use on prescription
medications. Our paper found inconsistent associations
between supplement use and compliance with prescription
medications. Given that long-term compliance is essential
to cardiac care, investigation into whether supplement use
disrupts compliance is warranted. This is particularly impor-
tant in population groups susceptible to noncompliance.
In addition, the reluctance of patients to disclose use of
dietary supplements may require patient and physician
education. Lastly, studies are needed to examine both health
and ﬁnancial costs of supplement use. Only one of the
reviewed studies examined the relative cost of CAM, ﬁnding
that patients of an Indian clinic were spending the same
amount on CAM and antihypertensive treatment, although
the authors note that the cost of mainstream care can be
reimbursed in most cases whilst CAM treatment cannot
[20]. Prospective studies can assess whether concomitant
use of prescription medications and supplements in cardiac
patients aﬀects outcomes such as morbidity, mortality, and
quality of life, while economic evaluation can determine
whether supplement use is cost eﬀective, especially given the
wide availability, increasing accessibility, and now common
use of dietary supplements.
In summary, the use of dietary supplements is common
in patients with cardiovascular conditions. There are no con-
clusive ﬁndings with respect to the health factors associated
with this use although many commonly used supplements
have the potential to interfere with the intended action of
prescription medications. A substantial number of treating
physicians are unaware of patients’ supplement use, and
consequently the eﬀects of supplementation on conventional
treatment may be overlooked. Disclosure of supplement use
can be facilitated if medical practitioners are more proactive
in questioning patients.
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